Dr. Reddy's Laboratories S.A. et al. vs. Eye Therapies, LLC et al.
Explore the PTAB proceeding IPR2024-00467 filed by Dr. Reddy's Laboratories S.A. et al. on 2024-01-24. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2024-00467
Filing Date
2024-01-24
Accorded Filing Date
2024-01-24
Institution Decision Date
2024-08-13
Last Modified Date
2025-07-22
Proceeding Type
IPR
Termination Date
2025-07-22
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Dr. Reddy's Laboratories S.A. et al.
Represented By
Cipriano, Linneaet alPatent Owner / Respondent
Eye Therapies, LLC et al.
Represented By
Diner, Bryanet alTribunal & Venue
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Patent Information
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 33885 | William Galliani | 650-843-5622 |
| 34262 | C Talbot | 703-456-8072 |
| 36343 | Matthew Langer | 212-497-6000 |
| 40673 | Heidi Keefe | 650-843-5000 |
| 41087 | Christopher Hutter | 703-456-8506 |
| 42669 | Brian Hopkins | 617-937-2300 |
| 42764 | Cynthia Kozakiewicz | 617-937-2300 |
| 43210 | Michael Tuscan | 202-842-7802 |
| 43255 | Bonnie Mcleod | 202-842-7800 |
| 44047 | Matthew Brigham | 650-843-5000 |
| 44546 | Kimberly Bolin | 650-543-5000 |
| 44614 | William Christiansen Ii | 206-452-8700 |
| 45409 | Heidi Erlacher | 617-937-2325 |
| 45899 | Christina Stock | 617-937-2300 |
| 47777 | Mika Mayer | 650-843-5000 |
| 47938 | William Shear | 858-550-6000 |
| 48199 | Lisa Amii | 650-843-5000 |
| 48907 | Dean Fanelli | 202-776-2050 |
| 50572 | Matthew Pavao | 617-937-2300 |
| 51909 | Carol Laherty | 206-452-8700 |
| 52292 | Connie Tong | 650-843-5000 |
| 55854 | Scott Weston | 617-937-2327 |
| 56393 | Daniel Knauss | 317-582-0173 |
| 57835 | Phillip Morton | 703-456-8000 |
| 59129 | Jeffery Wyzykowski | 202-842-7800 |
| 59307 | David Hopkins | 720-566-4063 |
| 60024 | Robert Wu | 650-943-5000 |
| 61254 | Alla Brukman | 202-842-7800 |
| 61689 | Margaret Fischofer | 703-456-8000 |
| 62305 | Jennifer Volk | 703-456-8575 |
| 63322 | Eamonn Gardner | 858-550-6086 |
| 64349 | Andrew Keith | 202-842-7800 |
| 64497 | Madhuri Roy | 650-843-5000 |
| 64911 | Mark Rogel | 206-452-8700 |
| 65144 | Samuel Whitt | 202-776-2316 |
| 65421 | Orion Armon | 720-566-4119 |
| 66418 | Jonathan Cousin | 202-842-7800 |
| 67971 | David Holly | 202-842-7800 |
| 68766 | Kenichi Hartman | 650-843-5227 |
| 68774 | Kassity Mai | 202-452-8800 |
| 69078 | Bethany Roahrig | 720-466-4178 |
| 70120 | Jeremy Binstock | 703-456-8000 |
| 70211 | Jason Valentine | 202-728-7157 |
| 70786 | Marcelo Pomeranz | 858-550-6146 |
| 70897 | Amy Motomura | 310-883-6559 |
| 71499 | Joanna Hubberts | 650-843-5098 |
| 71583 | Lesly Steinbeck | 212-479-6561 |
| 72201 | Michael Mcevoy | 202-842-7800 |
| 72629 | Anders Fernstrom | 703-456-8117 |
| 73102 | Michael Winternitz | 202-728-7034 |
| 73162 | Thomas Paxton | 617-937-2473 |
| 73384 | Chen Chen | 617-937-2384 |
| 73445 | Xiaomin Su | 202-776-2295 |
| 73668 | Aeraj Haque | 312-881-6714 |
| 73724 | Lawrence Teague | 206-452-8700 |
| 73852 | Jordan Phelan | 202-728-7066 |
| 74178 | Fraser Brown | 202-842-7850 |
| 74347 | Newman Han | 202-728-7047 |
| 75031 | Xiaozhen Yu | 202-728-7127 |
| 75736 | Xixi Sun | 617-477-2458 |
| 76165 | Fumin Shi | 202-776-2064 |
| 76239 | Dustin Knight | 571-643-5164 |
| 76259 | John Masters | 312-881-6407 |
| 76373 | Eric Owens | 212-479-6656 |
| 76421 | Meera Govindaraghavan | 202-663-7410 |
| 76534 | Mengke Mccullough | 858-550-6118 |
| 76605 | Matthew Scheideman | 202-842-7858 |
| 76692 | Asako Nagashima | 202-728-7054 |
| 76824 | Claudia Frehe | 202-842-7800 |
| 76859 | Nadeen Nsouli | 312-881-6698 |
| 76906 | Jessica Cande | 617-937-2348 |
| 77360 | Audrey Gallagher | 312-881-6717 |
| 77479 | Yin Nelson | 202-776-2088 |
| 77606 | Andrew Henderson | 425-503-7202 |
| 77755 | Scott Shaw | 650-843-5000 |
| 77802 | Robert Powers | 617-937-2490 |
| 77848 | Jordan Degayner | 312-881-6392 |
| 77930 | Mark Westwood | 650-843-5005 |
| 78052 | Alexia Dilg | 202-842-7815 |
| 78279 | Christine Dunne | 617-937-2337 |
| 78292 | Elizabeth Baez | 703-727-4270 |
| 78433 | David Schachter | 212-479-6815 |
| 78664 | Jill Kozumbo | 202-962-8384 |
| 78703 | Brendan Roach | 202-776-2180 |
| 79013 | Candace Britton | 650-543-5000 |
| 79226 | David Duron | 650-843-5604 |
| 79280 | Rachel Preston | 202-776-2315 |
| 79296 | Celeste Alvarez | 858-550-6000 |
| 79442 | Peter Chung | 703-456-8587 |
| 79458 | Sam Matthews | 617-937-2388 |
| 79575 | Felipe Guzman | 617-937-2381 |
| 79769 | Stephanie Johnson | 631-943-0991 |
| 79828 | Dou Yeon Youn | 212-479-6381 |
| 80140 | Philip Wdowiak | 312-881-6697 |
| 80181 | Natalie Hendrick | 617-937-1387 |
| 80447 | Claire Tourkin | 650-843-5138 |
| 80682 | Mengran Liu | 650-843-5114 |
| 80739 | Zhipeng Zheng | 202-776-2043 |
| 80762 | Taylor Canady | 212-479-6000 |
| 80787 | Jennifer Costigliola | 919-491-1109 |
| 80800 | Luke Sande | 617-937-2367 |
| 81166 | Nitasha Bennett | 858-550-6480 |
| 81181 | Georgia Calhoun | 858-550-6181 |
| 81333 | John Habibi | 202-776-2137 |
| 81446 | Ashley Sherrid | 206-452-8824 |
| 81515 | Nina Gu | 617-937-1459 |
| 81534 | Elif Ertem Bekdemir | 617-937-2354 |
| 81599 | Daniel Manson | 212-479-6835 |
| 81740 | Tian Yong Zheng | 206-452-8774 |
| 81797 | Rei Li | 212-479-6084 |
| 81816 | Michael Minsch Iv | 212-479-6610 |
| 81920 | Ying Yiu | 206-452-8825 |
| 81992 | Daniel Hinton | 617-937-2403 |
| 82124 | John Kozlowski | 858-550-6056 |
| 82294 | Kathleen Dinapoli | 202-842-7800 |
| 82583 | Maxwell Gonzalez | 650-843-5434 |
| 82694 | Austin Thind | 703-456-8593 |
| 82984 | Sarah Robbins | 202-776-2034 |
| 83259 | Ethan Decicco | 617-937-2312 |
| L1396 | Shanxi Feng | 202-776-2259 |
| L1408 | Gesa Junge | 212-479-6658 |
Proceeding Documents
200TERMINATION Due to Settlement After Institution of Trial 35 U.S.C. § 317; 37 C.F.R. § 42.74 TERMINATE
Joint Request to File Settlement Agreement as Business Confidential and to Keep It Separate from Patent Files MOTION
Joint Motion to Terminate MOTION
Patent Owner's Seventh Updated Exhibit List NOTICE
Ex. 3006 Motion to Terminate Exhibit
Other: Hearing transcript OTHER
Patent Owner's Demonstratives OTHER
Petitioners' Demonstratives OTHER
Joint Stipulation to Modify Schedule for Exchanging Demonstratives OTHER
Order: Setting Oral Argument ORDER
EX-2279 Deposition of John Galanis, M.D., FACS Exhibit
Patent Owner's Sixth Updated Exhibit List NOTICE
Patent Owner's Sur-Reply OTHER
EX-2280 Deposition of Daniel Gil, Ph.D. Exhibit
EX-2281 Deposition of Anthony Masztak Exhibit
Patent Owner's Notice of Deposition of Anthony M. Masztak NOTICE
Panel Change Order ORDER
Petitioners' Fourth Updated Exhibit List NOTICE
Patent Owner's Request for Oral Hearing OTHER
Petitioners' Request for Oral Argument OTHER
Exhibit 1203 - Expert Declaration of Anthony M. Masztak in Support of Petitioners' Reply (Redacted) Exhibit
Petitioners' Motion to Seal MOTION
Exhibit 1202 - Masztak CV Exhibit
Joint Stipulation to Change Due Date 3 NOTICE
E-mail authorizing counsel substitution Exhibit
Patent Owner's Amended Notice of Deposition of John C. Galanis, MD, FACS NOTICE
Patent Owner's Amended Notice of Deposition of Ivan T. Hofmann, C.P.A., C.F.F., C.L.P. NOTICE
Patent Owner's Notice of Deposition of John C. Galanis, MD, FACS NOTICE
Patent Owner's Notice of Deposition of Ivan T. Hofmann, C.P.A., C.F.F., C.L.P. NOTICE
Patent Owner's Objections to Petitioners' Exhibits OTHER
Petitioners' Motion to Seal MOTION
Exhibit 1186 - LumifyEyes – Lumify Eye Illuminations Exhibit
Exhibit 1181 - MUSE Awards 2019 Silver Winner Information Exhibit
Exhibit 1200 - Barry’s Instagram Exhibit
Exhibit 1188 - 2022.11.02 IPR2022-00142 Ferris Deposition Transcript - REDACTED Exhibit
Exhibit 1191 - FTC Disclosures 101 for Social Media Influencers Exhibit
Exhibit 1177 - Barry’s Find Your Strength Exhibit
Exhibit 1070 - Sklubalova 2006 Exhibit
Exhibit 1185 - Businesswire – Lumify Eye Illuminations Exhibit
Exhibit 1054 - 2024.01.21 Donnenfeld PI Deposition Transcript Exhibit
Exhibit 1170 - DRL Form 20-F for Fiscal Year 2023-2024 Exhibit
Exhibit 1147 - 2025.02.25 Reply Declaration of John C. Galanis Exhibit
Exhibit 1163 - CV of Ivan T. Hofmann Exhibit
Exhibit 1193 - TikTok OrionSisters Video Exhibit
Exhibit 1058 - ARVO Glossary Exhibit
Exhibit 1187 - FiercePharma – Bausch + Lomb kicks off TikTok Challenge for Lumify Exhibit
Exhibit 1194 - Bausch + Lomb #LUMIFYEyeDance Challenge Wins 2022 Public Relations Exhibit
Exhibit 1190 - TikTok Lumify Eye Dance (November 2022) Exhibit
Exhibit 1031 - 2023.12.31 Gil PI Deposition Transcript Exhibit
Petitioners' Reply REPLYTOOPP
Exhibit 1171 - IPR2022-00142 Declaration of Ivan T. Hofmann - REDACTED Exhibit
Exhibit 1168 - Patent Assignment for US 11833245 Exhibit
Exhibit 1059 - Decoding Your Prescriptions: Understanding Pharmacy Abbreviations Exhibit
Exhibit 1201 - US Patent No. 9,259,425 Exhibit
Exhibit 1045 - 2025.02.13 Stamer IPR Deposition Transcript Exhibit
Exhibit 1178 - HG 2019 Muse Creative Awards Exhibit
Exhibit 1173 - Bausch Health 2019 Q2 Earnings Call Transcript Exhibit
Exhibit 1175 - Bausch Health 2021 Q4 Earnings Call Transcript Exhibit
Exhibit 1189 - PR NewsWire – Bausch + Lomb Launches #LUMIFYEyeDance Exhibit
Exhibit 1184 - Wavemaker Global – Our Work Exhibit
Exhibit 1047 - 2025.02.19 Noecker IPR Deposition Transcript Exhibit
Exhibit 1174 - Bausch Health 2020 Q4 Earnings Call Transcript Exhibit
Exhibit 1172 - Bausch Fourth Quarter 2018 Earnings Call Transcript Exhibit
Exhibit 1044 - 2025.02.06 Donnenfeld IPR Deposition Transcript Exhibit
Exhibit 1129 - IPR2022-00142 Noecker Declaration - REDACTED Exhibit
Exhibit 1162 - 2025.02.25 Declaration of Ivan T. Hofmann - REDACTED Exhibit
Exhibit 1183 - Wavemaker Global – Two Gold Effies Exhibit
Exhibit 1169 - Lumify Label Exhibit
Exhibit 1182 - MUSE Awards 2019 Rose Gold Winner Information Exhibit
Exhibit 1072 - 2024.02.19 Williams PI Deposition Transcript Exhibit
Exhibit 1180 - MUSE Awards Exhibit
Exhibit 1179 - HG Agency Exhibit
Exhibit 1069 - Sklubalova 2005 Exhibit
Exhibit 1167 - Lumify Orange Book Patent List Exhibit
Exhibit 1048 - 2025.01.28 Williams IPR Deposition Transcript Exhibit
Exhibit 1195 - Event Marketer Coachella 2024 Experimental Marketing Exhibit
Exhibit 1192 - TikTok Allanface Video Exhibit
Exhibit 1198 - IPR2022-00142 Jarosz Declaration - REDACTED Exhibit
Exhibit 1053 - 2022.11.13 IPR2022-00142 Noecker Deposition Transcript Exhibit
Exhibit 1199 - 2022.11.11 IPR2022-00142 Jarosz Deposition Transcript Exhibit
Patent Owner's Updated Mandatory Notices NOTICE
ORDER Denying without Prejudice Petitioner’s Motion for Additional Discovery 37 C.F.R. § 42.51(b)(2)(i) ORDER
ORDER Granting Patent Owner’s Motion for Pro Hac Vice Admission of Matthew J. Luneack 37 C.F.R. § 42.10 ORDER
Patent Owner's Fifth Updated Exhibit List NOTICE
Patent Owner's Opposition to Petitioners' Motion for Additional Discovery OPPOSITION
EX-2276 - Email chain regarding Depositions Exhibit
Petitioners' Second Updated Mandatory Notices NOTICE
EX-2278 - Email chain regarding cross use agreement Exhibit
EX-2277 - Order Granting Motion to Stay Exhibit
Patent Owner's Updated Exhibit List NOTICE
Patent Owner's Motion for Admission Pro Hac Vice of Matthew J. Luneack MOTION
EX-2270_Declaration of Matthew J. Luneack in Support of Motion for Admission Pro Hac Vice Exhibit
Order: Granting Petitioner’s Motion for Pro Hac Vice Admission of Timothy J. Beavers 37 C.F.R. § 42.10 ORDER
Petitioners' Notice of Deposition of Robert J. Noecker NOTICE
Exhibit 1039 - District Court Protective Order Exhibit
Petitioners' Motion for Additional Discovery MOTION
Petitioners' Third Updated Exhibit List NOTICE
Ex. 3004 Exhibit
Stipulated Proposed Protective Order OTHER
Exhibit 1033 - Declaration of Robert Frederickson III in Support of Notice of Intent to Designate Provisionally Recognized PTAB Attorney as Back-Up Counsel Under 37 C.F.R. Section 42.10(c) Exhibit
Petitioners' Unopposed Notice of Intent to Designate Provisionally Recognized PTAB Attorney Elaine Blais as Back Up Counsel Under 37 C.F.R. Section 42.10(c) NOTICE
Exhibit 1036 - Declaration of Elaine H. Blais in Support of Notice of Intent to Designate Provisionally Recognized PTAB Attorney as Back-Up Counsel Under 37 C.F.R. Section 42.10(c) Exhibit
Petitioners' Unopposed Notice of Intent to Designate Provisionally Recognized PTAB Attorney Robert Frederickson III as Back Up Counsel Under 37 C.F.R. Section 42.10(c) NOTICE
Exhibit 1036 - Declaration of Elaine H. Blais in Support of Notice of Intent to Designate Provisionally Recognized PTAB Attorney as Back-up Counsel Under 37 C.F.R. Section 42.10(c) Exhibit
Exhibit 3003 Exhibit
Petitioners' Notice of Deposition of Dr. Robert Williams III NOTICE
Petitioners' Notice of Deposition of Dr. Daniel Gil NOTICE
Exhibit 1033 - Declaration of Robert Frederickson III in Support of Notice of Intent to Designate Provisionally Recognized PTAB Attorney as Back-up Counsel Under 37 C.F.R. Section 42.10(c) Exhibit
Petitioners' Unopposed Notice of Intent to Designate Provisionally Recognized PTAB Attorney Elaine Blais as Back Up Counsel Under 37 C.F.R. Section 42.10(c) NOTICE
Petitioners' Notice of Deposition of Dr. Eric Donnenfeld NOTICE
Petitioners' Unopposed Motion for Pro Hac Vice Admission of Timothy J. Beavers Under 37 C.F.R. Section 42.10(c) MOTION
Exhibit 1038 - Declaration of Timothy Beavers in Support of Motion for Pro Hac Vice Admission Under 37 C.F.R. Section 42.10(c) Exhibit
Petitioners' Second Updated Exhibit List NOTICE
Petitioners' Notice of Deposition of John Ferris NOTICE
Petitioners' Notice of Deposition of Kurt R. Karst NOTICE
Petitioners' Unopposed Notice of Intent to Designate Provisionally Recognized PTAB Attorney Robert Frederickson III as Back Up Counsel Under 37 C.F.R. Section 42.10(c) NOTICE
Petitioners' Notice of Deposition of Dr. W. Daniel Stamer NOTICE
Petitioner's Notice of Deposition of John Jarosz NOTICE
Petitioners' Updated Mandatory Notices NOTICE
Petitioners' Updated Power of Attorney NOTICE
Petitioners' Objections to Patent Owner's Evidence Submitted with Patent Owner's Response OTHER
EX-2162-(cleareyes.com Complete Sensitive Eyes) Exhibit
EX-2138-Lumify Supplemental Approval Apr 30, 2019 Exhibit
EX-2190-Eye Therapies Company Profile Valuation-PitchBook Exhibit
EX-2194-When to Prescribe an OTC Allergy Drop Exhibit
EX-2077_LUMIFY LEGAL DATA OCTOBER 2024 (Public) Exhibit
EX-2117_Gil 2009 Exhibit
EX-2131-BAU-LUM00063901 Exhibit
EX-2136-LUMIFY LEGAL DATA POS JULY 2022 (Public) Exhibit
EX-2098_OTC Drug Review Process_OTC Drug Monographs_FDA Exhibit
EX-2039_Madhu Exhibit
EX-2168-(cvs.com Lumify Redness Reliever) Exhibit
EX-2151-(2021 FY Presentation) Exhibit
EX-2157-(bausch.com locations) Exhibit
EX-2167-(cvs.com eye drops lubricants) Exhibit
EX-2199-Rohto Max Strength Redness Relief Eye Drops Exhibit
EX-2051_Qoliana Label (2006) Exhibit
EX-2074_Lumify Incremental to Eye Care and Red Relivers Category 11-03-24 (003) (Public) Exhibit
EX-2114_Woldmussie 2001 Exhibit
EX-2145_(2022 Q1 10Q) Exhibit
EX-2106_Enhancing the Management of Red Eye Exhibit
EX-2212- Contact Us-Good Health Can't Wait Exhibit
EX-2186-B&L licenses new technology for treating ocular redness Exhibit
EX-2141-Lumify Supplemental Approval Nov 29, 2021 Exhibit
EX-2165-(cleareyes.com Redness Relief Directions) Exhibit
EX-2219-US Securities and Exchange Commision FORM 10-Q Exhibit
EX-2095_Bausch Press Release (2022) Exhibit
EX-2215- Supplemental Approval Exhibit
EX-2147-(Bausch Jan 2022 S-1)_Part 1 of 3 Exhibit
EX-2146-(2022 Q1 Presentation) Exhibit
EX-2034_Allergan Press Release (2002) Exhibit
EX-2223_Declaration of Robert J. Noecker, M.D., MBA (Public) Exhibit
EX-2125-IRI Report New Product Pacesetters May 2020 Exhibit
EX-2113_Kusari 2011 Exhibit
EX-2052_(glamour.com) Exhibit
EX-2126-Carlton and Perloff 2015_Part 1 of 2 Exhibit
EX-2147-(Bausch Jan 2022 S-1)_Part 3 of 3 Exhibit
EX-2137-Visine Supplemental Approval Oct 17, 2018 Exhibit
EX-2128-Spiegel and Gerber 1959 Exhibit
EX-2100_IPR2024-00467 Depo Tr. Dana, Nov. 1, 2024 Exhibit
EX-2101_Uretmen 2003 Exhibit
EX-2072_LUMIFY PnL 93024 (Public) Exhibit
EX-2084_Middleton Auvelity Exhibit
EX-2046_NDA 208144, Section 2.3.P.1.1 (Public) Exhibit
EX-2033_Drug Appl Process for Nonprescription Drugs Exhibit
EX-2103_10-100-0008 Clinical Study Report (Public) Exhibit
EX-2178-(ir.bauschhealth.com name change) Exhibit
EX-2036_Alphagan P (0.1%) Approval Letter 2005 Exhibit
EX-2083_Picture of an Eye Exhibit
EX-2208-Lumify vs. Visine Exhibit
EX-2143-(Lumify NDA Approval) Exhibit
EX-2037_Debbasch 2000_Ex. 446 Exhibit
Ex-2120_Flammer 2002 Exhibit
EX-2149-(2018 Annual Report) Exhibit
EX-2061_NewBeauty_Spring2023_Cover and Feature Exhibit
EX-2063_LUMIFY September 2024 Business (Public) Exhibit
EX-2045_FDA Approves Preservative-Free Drug to Treat Glaucoma Exhibit
EX-2160-(businesswire.com) Exhibit
EX-2099_Drugs@FDA Alphagan 0.5% Exhibit
Patent Owner's Response (Public) RESPONSE
EX-2110_Schuman 1997 Exhibit
EX-2144-(Lumify NDA Summary) Exhibit
EX-2105_13-100-0005 Clinical Study Report (Public) Exhibit
EX-2126-Carlton and Perloff 2015_Part 2 of 2 Exhibit
EX-2081_Huang Exhibit
EX-2054_(newyou.com) Exhibit
EX-2187-Bausch Patents Exhibit
EX-2206-walgreens - Redness Relief Exhibit
EX-2229_Declaration of John C. Jarosz (Public) Exhibit
EX-2179-(ir-nielsen-com Capitalizing On Innovation) Exhibit
EX-2086_Yassen 2007 Exhibit
EX-2184-FDA App Lumify a Brimonidine OTC for Ocular Redness Exhibit
EX-2169-(DailyMed Rohto Cool Drug Info) Exhibit
EX-2154-(accessdata.fda.gov approved drugs) Exhibit
EX-2182-The Science of Lumify Exhibit
EX-2211- Who are we Exhibit
EX-2183-The Secret of Successful Drug Launches Exhibit
EX-2189 - advanced-eye-relief-maximum-redness-drug-facts Exhibit
EX-2035_Drugs@FDA - Alphagan P 0.15% Exhibit
EX-2094_Belmonte 2004 Exhibit
Download Proceeding Documents
Case IPR2024-00467 • 200 documents
Preparing ZIP Archive
Email verified! Bundling proceeding documents from USPTO. Your download will start automatically in a few seconds...